Are CME Group Stocks Outperforming the Dow Jones?

CME Group Inc. (CME), headquartered in Chicago, Illinois, operates contract markets for the trading of futures and options on futures contracts. Valued at $115.2 billion by market capitalization, the company offers futures and options products based on interest rates, stock indices, currencies, agricultural commodities, energy and metals, and more. It facilitates trading on its trading floors, electronic platform and through privately negotiated transactions that compensate.

Companies worth $10 billion or more are generally described as “large-cap stocks.” CME fits that bill perfectly, as its market capitalization exceeds this mark, underscoring its size, influence, and dominance within the financial data and stock exchange industry. CME consolidates its leadership in the derivatives market with a wide range of trading products covering interest rates, stock indices, foreign currencies and commodities. This broad portfolio attracts a broad client base, granting exclusive rights to trade and settle S&P futures contracts, further cementing its competitive advantage.

Despite its notable strength, CME fell 1% from its 52-week high of $322.57, reached on February 25. Over the past three months, CME shares have gained 13.8%, outpacing the Dow Jones Industrials Average ($DOWI)’s 3.3% gains over the same time period.

CME shares are up 17% year to date and 27.9% over the past 52 weeks, outperforming DOWI’s year-to-date gains of 1.9% and strong returns of 13.3% over the past year.

Confirming the bullish trend, CME has been trading above its 200-day moving average for the past year, with slight fluctuations. The stock has been trading above its 50-day moving average since early November 2025, with minor fluctuations.

CME’s strong performance is driven by broad-based growth across all asset classes and higher retail participation, with key drivers including increased activity in interest rates, energy, metals, agriculture and crypto products. The company is focused on launching new initiatives such as securities clearing, 24/7 cryptocurrency trading, and additional cryptocurrency futures, while maintaining cost discipline and driving innovation.

On February 4, CME stock closed slightly higher after reporting its fourth-quarter results. Its adjusted EPS of $2.77 beat Wall Street expectations of $2.75. The company’s revenue was $1.7 billion, beating Wall Street forecasts of $1.6 billion.

In the competitive arena of financial data and stock exchanges, Intercontinental Exchange, Inc. (ICE) has lagged CME, with a rally of 1.3% year over year and losses of 3.9% over the last 52 weeks.

Wall Street analysts are reasonably optimistic about CME’s prospects. The stock has a consensus rating of “Moderate Buy” from the 17 analysts who cover it. While CME is currently trading above its average price target of $304.27, the Street’s high price target of $340 suggests 6.4% upside potential.

On the date of publication, Neha Panjwani had no (directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article are for informational purposes only. This article was originally published on Barchart.com